XRTX
XORTX Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website xortx.com
- Employees(FY) 3
- ISIN CA98420Q3061
Performance
+6.27%
1W
-26.76%
1M
+23.13%
3M
-15.89%
6M
+17.32%
YTD
-56.36%
1Y
Profile
XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and acute kidney injury (AKI) associated health consequences; and XRX-225, a program for treatment of type 2 diabetic nephropathy. The company has a collaboration and license agreements with the Icahn School of Medicine to study the incidence of AKI and hyperuricemia in patients hospitalized with COVID-19; and with the University of Florida Research Foundation, Inc. XORTX Therapeutics Inc. is based in Alberta Beach, Canada.
Technical Analysis of XRTX 2024-05-03
Overview:
In analyzing the technical indicators for XRTX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
- 2024-04-30 01:54
- 2024-04-21 19:00
XORTX Announces Publication of Key Research in ADPKD(Globenewswire)
- 2024-04-07 19:30
XORTX Welcomes New Member to the Board of Directors(Globenewswire)
- 2024-04-07 19:00
- 2024-03-26 17:00
XORTX Announces New Clinical Advisory Board Member(Globenewswire)
- 2024-03-18 21:30
- 2024-03-18 17:00
- 2024-03-10 19:00
- 2024-03-03 18:00
- 2024-02-14 18:00
- 2024-02-01 07:46
- 2024-01-14 18:00
XORTX Announces $2 Million Public Offering(Globenewswire)
- 2024-01-02 18:00
- 2024-01-01 18:00
XORTX Welcomes New Member to the Board of Directors(Globenewswire)
- 2023-11-29 18:30
XORTX Announces US ATM Offering(Globenewswire)
- 2023-11-28 18:00
XORTX Meets Nasdaq Continued Listing Requirements(Globenewswire)
- 2023-11-09 18:00
XORTX Clarifies Timing for Share Consolidation(Globenewswire)
- 2023-11-08 04:00
XORTX Announces Share Consolidation(Globenewswire)
- 2023-11-01 19:00
- 2023-10-27 05:30
XORTX Announces Results of Special Meeting of Shareholders(Globenewswire)
- 2023-10-25 05:00
- 2023-10-24 19:00
- 2023-10-22 21:10
Why Is Xortx Therapeutics (XRTX) Stock Down 27% Today?(Investorplace)
- 2023-10-19 20:42
Why Is Xortx Therapeutics (XRTX) Stock Up 110% Today?(Investorplace)
- 2023-10-11 19:00
- 2023-10-03 19:00
XORTX Calls Special Meeting of Shareholders(Globenewswire)
- 2023-09-27 19:00
- 2023-09-10 19:00
- 2023-09-06 19:00
XORTX Joins the Kidney Foundation and Kidney March(Yahoo Finance)
- 2023-08-28 19:00
Page 1 of 4
previousnext